promoted similar cellular effects even after being challenged with proinflammatory cytokines and bacterial virulence factors.
Conclusion:
Periostin acts as an important modulator of hPDL cell-matrix dynamics. It modulates hPDL proliferation, migration and PI3K/AKT/mTOR pathway. It also helps in overcoming the altered biological phenotype that chronic exposure to periodontal pathogens and proinflammatory cytokines produce in hPDL cells.
The tooth-supporting apparatus (i.e. periodontium) includes the alveolar bone, periodontal ligament (PDL), cementum and gingiva. The periodontium is a highly specialized adaptive dynamic tissue able to sustain different microbiological, inflammatory and mechanical challenges through a number of complex molecular events involving growth factors, transcription factors and extracellular matrix (ECM) proteins (1, 2) .
In humans, microbially induced inflammatory periodontal diseases are the primary initiators that disrupt the functional and structural integrity of the periodontium. Different forms of periodontal diseases virtually affect the entire population (3, 4) , which constitutes a true public health concern. Moreover, once the periodontal breakdown occurs, the ideal restoration (i.e. regeneration) of its original structure, properties and function is a significant challenge in the clinical setting (5) . Efforts have been made on regenerating lost alveolar bone. However, regeneration of the lost periodontium involves the formation of all toothsupporting structures in a temporal and spatial progress (6) . Although the exact cellular and molecular events are still not clear, specific cells must first migrate to the healing area and proliferate. This process is mediated and coordinated by soluble factors, other cells, ECM and matricellular proteins. Normal mechanical stimuli will increase and promote an organized ECM synthesis and organization as well as cementum and bone formation and maturation. Once those structures are established, PDL fibers are organized and oriented, connecting the tooth to the alveolar bone (7) .
In this context, matricellular molecules within the PDL provide signals to the constituent cell populations to modulate their phenotype to maintain tissue homeostasis. Periostin (gene POSTN), a secreted adhesion molecule highly specific to the PDL, mainly secreted by fibroblasts (8) , is essential for the periodontal tissue integrity and homeostasis and plays an important role in tooth development and eruption processes (2, 9, 10) . Periostin is induced by biomechanical stimuli via transforming growth-ß1 signaling (2) and regulates collagen fibrillogenesis and tissue strength (11, 12) . However, it is reduced by the effect of inflammatory cytokines and bacterial virulence factors (13) . Levels of periostin are inversely correlated to the extent of alveolar bone loss (14) . Periostin has been suggested to modulate the connective tissue repair and remodeling in cardiac tissue (15) and skin (16) by the activation of the cell survival AKT/PKB pathway (17) . It has also shown an increase in smooth muscle cell migration via avb3 and avb5-integrins and phosphorylation of FAK (18) . However, the role of periostin in periodontal regeneration and PDL cells has still not been described.
Therefore, the aim of this study was to analyze the effects of recombinant periostin supplementation on the regenerative potential of human PDL (hPDL) cells in terms of cell proliferation and migration capacities as well as the activation of the PI3K/AKT/ mTOR survival signaling pathway. The ability of periostin to recover cell activity after being challenged by proinflammatory cytokines and bacterial virulence factors was also analyzed.
Material and methods

Cell populations
Primary hPDL cells were characterized and used as previously reported (13) . The use of human cells was approved by the University of Michigan Institutional Review Board. Cells were maintained in Dulbecco's modified Eagle's medium (Gibco, Life Technologies Corporation, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco), antibiotics (100 units/mL penicillin and 100 lg/mL streptomycin), antifungal (1 : 1000 amphotericin B) and 2 mM glutamine, at 37°C in a humidified atmosphere of 95% air/5% CO 2 . Cells were removed from the growth surface with a trypsin solution [0.25% trypsin, 0.1% glucose, citrate-saline buffer (pH 7.8); Gibco] and subsequently used for experiments. Cells were used between passages 5 and 8 for experiments.
Cell culture conditions
Cells were seeded in six-well plates. At 70% confluence, media was substituted with starving media (no fetal bovine serum). After 24 h, wells were assigned to four different groups and media changed and supplemented accordingly: C (control), P100 (recombinant human periostin, 100 ng/mL; R&D Systems Inc., Minneapolis, MN, USA), P50 (periostin, 50 ng/mL), and fibroblast growth factor (FGF)-2 as positive control (recombinant human FGF-2, 10 ng/mL; Gibco).
To investigate the capacities of recombinant periostin to recover cell capacities in a challenged environment, a similar set of cultures were subjected to chronic exposure (4 d) to TNF-a + P. gingivalis lipopolysaccharide (LPS) (T + L: 10 ng/mL TNF-a; Abcam Inc., Cambridge, MA, USA; 200 ng/mL P. gingivalis LPS), known to reduce periostin expression and extracellular deposition by hPDL cells (13) . Then, cell cultures were subjected to starving media for 24 h and supplemented with periostin or FGF-2 as described above.
Three separate experiments with the different media supplementations were performed in triplicate for all primary hPDL populations for all assays.
Analysis of cell proliferation by Ki67
For Ki67 staining, cells were seeded into a 16-well Lab-Tek TM Chamber Slide TM System (Thermo Fisher Scientific, Waltham, MA, USA) at 50% confluence. After 24 h of starving, cells were subjected to the same conditions described above. Six hours later, the culture medium was removed, cells were washed twice with phosphate-buffered saline (PBS), and fixed in 100% cold methanol for 5 min. Cells were then washed again, and blocked in 3% bovine serum albumin (BSA)-PBS for 1 h. Immunofluorescence staining for Ki67 was performed using a mouse monoclonal antibody to human Ki67 overnight (1 : 100 dilution in 3% BSA-PBS; Dako North America, Inc., Carpinteria, CA, USA). The immunological reaction was visualized by using a secondary antibody to mouse conjugated with fluorescein isothiocyanate for 1 h (1 : 100 dilution in 3% BSA-PBS). Slides were then treated with an antifade agent containing DAPI (ProLong â Gold antifade reagent with DAPI; Invitrogen, Life Technologies Corporation) and covered with glass coverslips. All stained slides were imaged using an OLYM-PUS Fluoview 500 confocal microscope (Olympus America Inc., Center Valley, PA, USA) using the same settings. Three images per well were captured. Three separate experiments with the different media supplementations in triplicate were performed for all primary hPDL populations. Ki67-positive cells (green) and total cell number (DAPI staining, blue) were counted to calculate the mean percentage of positive cells per group and normalized to the control.
Scratch migration assay
A scratch-simulated wound migration assay was performed to assess the effect of exogenous periostin supplementation. hPDL cells were seeded on to six well plates and allowed to grow close to 95% confluence. After 24 h of starving, a scratch was performed along the diameter of the well (19) and the scraped cells were removed by washing with PBS. Fresh culture media was added and supplemented with each one of the treatment groups as described above. After that, images from the same area were taken from 0 to 48 h after the scratch with a 6 h interval at 49. Three separate experiments with the different media supplementations in triplicate were performed for all primary hPDL populations. The scraped area was measured by ImageJ software (National Institute of Health, USA; http://rsbweb.nih.gov/ij/). The wound area over time was measured considering the area at time 0 as 100%.
Survival pathway activation analysis
Six hours after media supplementation, supernatant was removed, cells were washed twice with PBS and collected by scraping. Cells suspended in PBS were spun at 3500 g for 10 min at 4°C to pellet the cells. Cell pellets were resuspended in lysis buffer (0.1 M Tris pH 6.8, 2% SDS, 1% b-mercaptoethanol, 1 : 100 protease inhibitor cocktail), vortexed for 5 min and incubated on ice for 30 min. The lysates were centrifuged again (14,000 g for 10 min at 4°C) and protein supernatants were collected.
Total protein concentration was quantified using the Quant-iT â Pro- Western blot band signals were semi-quantified using ImageJ software (National Institute of Health). Immunopositive bands for each group were adjusted by GAPDH and the intensity fold changes normalized by assigning a relative value of 1 to the control group.
Statistical analysis
PASW Statistics 18.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. All data are presented as the means AE SEM. The significance of the differences among groups was determined by using the ANOVA test (a = 0.05). Fisher least significant difference test was used to define pairwise statistical differences (a = 0.05).
Results
Periostin increases human periodontal ligament proliferation, migration and activates survival pathways
Under non-challenged conditions, immunofluorescence staining for Ki67 proliferation marker demonstrated that periostin 100 ng/mL (2.02 AE 0.21), 50 ng/mL (1.99 AE 0.18) and FGF-2 (1.92 AE 0.20) significantly increased hPDL cell proliferation by approximately twofold compared to control (1.00 AE 0.16) (p < 0.004; p < 0.005; p < 0.008, respectively) ( Fig. 1 ; values of Ki67-positive cell percentages per group normalized to control).
hPDL cell migration analyzed by scratch assay was significantly accelerated by the addition of periostin or FGF-2 at every time point compared to the control group (Fig. 2) . The highest concentration of periostin (100 ng/mL) showed a very similar effect as that achieved by the positive control FGF-2. Interestingly, the addition of 50 ng/mL of periostin showed a greater improvement, especially at earlier time points (up to 18 h), with statistically significant effects even when compared to FGF-2 (p < 0.001) and periostin 100 ng/mL (p < 0.003), as early as 6 h (Fig. 2B) .
In terms of survival pathway activation under non-challenged conditions ( Fig. 3 ; relative values of signal intensities compared to the control condition), there was an increase in detection of total AKT depending on the groups: 1 AE 0.55, 1.62 AE 0.67, 2.57 AE 1.28 and 6.75 AE 2.08 (control, periostin 100 ng/mL, 50 ng/mL and FGF-2, respectively; Fig. 3B ). In terms of phosphorylation of AKT, there was an increase in periostin 50 ng/mL and FGF-2 groups compared to control and periostin 100 ng/ mL: 1 AE 0.16, 0.47 AE 0.1, 1.57 AE 0.26 and 1.35 AE 0.13 (control, periostin 100 ng/mL, 50 ng/mL and FGF-2, respectively; Fig. 3C ). The increase in periostin 50 ng/mL and FGF-2 groups was statistically significant compared to periostin 100 ng/mL (p < 0.011 for periostin 50 ng/mL; p < 0.022 for FGF-2). Similarly, PS-6 followed the same pattern: 1 AE 0.12, 0.1 AE 0.03, 3.52 AE 0.18 and 3.61 AE 0.06 (control, periostin 100 ng/mL, 50 ng/mL and FGF-2, respectively; Fig. 3D ). Compared to control or periostin 100 ng/mL, phosphorylation of protein S6 was significantly higher when periostin 50 ng/mL (p < 0.001) or FGF-2 (p < 0.001) were added. Interestingly, phosphorylation of protein S6 was significantly lower when periostin 100 ng/mL was added (p < 0.005).
Periostin increases human
showed that only the addition of periostin 100 ng/mL (1.59 AE 0.11) and FGF-2 (1.41 AE 0.12) showed statistically significant differences compared to the control group (1.00 AE 0.16; p < 0.002 and p < 0.026, respectively). However, and more interestingly, when compared to the TNF-a + P. gingivalis LPS group (0.85 AE 0.14), all groups, including the addition of periostin 50 ng/mL (1.31 AE 0.08), showed statistically significant differences (p < 0.001, p < 0.008 and p < 0.003; T + L + P100, T + L + P50 and T + L + FGF-2, respectively; Fig. 4 ) (values of Ki67-positive cell percentages per group normalized to control).
In terms of migration, the addition of periostin or FGF-2 improved the effects compared to TNF-a + P. gingivalis LPS alone (Fig. 5) . Interestingly, the effects of periostin (50 and 100 ng/mL) were more noticeable at earlier time points (6 h), when the migration capacities were better than the positive control FGF-2 compared to TNF-a + P. gingivalis LPS (p < 0.022, p < 0.045 and p = 0.224; T + L + P100, T + L + P50 and T + L + FGF-2, respectively). Interestingly, the effects of periostin under challenged conditions improved migration to levels similar to those under non-challenged conditions. At later time points (more than 24 h), the differences between T + L + P100 and TNF-a + P. gingivalis LPS alone were not statistically significant. At those time points, only the addition of 50 ng/mL of periostin or FGF-2 showed significant improvements compared to TNF-a + P. gingivalis LPS alone; those two groups (T + L A B + P50 and T + L + FGF-2) were not different between themselves. Furthermore, the effects of periostin 50 ng/ mL between 18 and 36 h were comparable to the non-challenged control group (Fig. 5B) . In terms of survival pathway activation under challenged conditions, previous observations were markedly evident ( Fig. 6) (relative values of signal intensities compared to the control condition). In this scenario, even though total AKT was significantly higher in all groups compared to the control group (8.02 AE 1.42, 9.22 AE 0.02, 8.71 AE 0.85 and 14.5 AE 1.025; p < 0.003, p < 0.001, p < 0.002 and p < 0.001; T + L, T + L + P100, T + L + P50 and T + L + FGF-2, respectively; Fig. 6B ), the addition of TNF-a + P. gingivalis LPS markedly decreased phosphorylation of this molecule compared to control, except when FGF-2 was present: 0.08 AE 0.01, 0.21 AE 0.08, 0.68 AE 0.07 and 0.81 AE 0.05 (p < 0.001, p < 0.001, p < 0.046 and p = 0.184; T + L, T + L + P100, T + L + P50 and T + L + FGF-2, respectively; Fig. 6C ). When compared to TNF-a + P. gingivalis LPS, only the addition of periostin 50 ng/mL (p < 0.005) and FGF-2 (p < 0.002) significantly increased phosphorylation of AKT (Fig. 6C) . Interestingly, phosphorylation of protein S6 was significantly higher than in the control group only with the addition of periostin or FGF-2: 1.3 AE 0.19, 2.71 AE 0.1, 4.68 AE 0.08 and 7.66 AE 0.3 (p = 0.287, p < 0.001, p < 0.001 and p < 0.001; T + L, T + L + P100, T + L + P50 and T + L + FGF-2, respectively; Fig. 6D ). When compared to TNF-a + P. gingivalis LPS alone, the addition of periostin 100 ng/mL (p < 0.002), periostin 50 ng/mL (p < 0.001) and FGF-2 (p < 0.001) significantly increased phosphorylation of protein S6 (Fig. 6D) .
Discussion
Regeneration of the tooth-supporting apparatus has become a major challenge in dentistry (20) as well as a highly demanded treatment due to the high prevalence and impact that periodontal diseases have in the daily periodontal practice (3). Periostin is primarily expressed by PDL fibroblasts (8) . It is localized between the cytoplasmic processes of periodontal fibroblasts and cementoblasts and the adjacent collagen fibers (21) . Periostin is required for the integrity and homeostasis of the PDL under normal physiological occlusal load (2,9,10). When not present or reduced, periodontal tissues break down, possibly due to the reduction on collagen fiber diameter and the subsequent tissue strength degradation (12) . Within the context of periodontal disease, periostin is reduced by the effect of inflammatory cytokines and bacterial virulence factors (13) and it is inversely related to the extent of bone alveolar loss (14) . Therefore, restoration of proper levels of this molecule in the PDL environment may have a key implication in the restoration of its original structure and function.
Periostin has been previously shown to increase cell survival and proliferation rates in different tissues, including skin (16) and heart (15, 22, 23) . It plays a role in angiogenesis (24) . Higher levels have been reported as key in cancer development, proliferation and metastasis (25, 26) . Such effects of periostin are mediated by integrins avb1, avb3 and avb5-integrins (17, 27) , which further activate the downstream cascade of the PI3K/AKT signaling pathway to induce cell proliferation, as well as phosphorylation of FAK to induce cell migration (18) . Our results in hPDL cells show high similarities with previous reports. The present study confirms a PI3K/AKT-dependent migration and proliferation signaling cascade activated by periostin toward phosphorylation of the ribosomal protein S6, the final step of the mTORC1 pathway after activation of p70-S6 Kinase 1 (S6K1), especially with lower dose (50 ng/mL) ( Fig. 3 ) (28) . In fact, in terms of cell proliferation, as analyzed by Ki67 immunofluorescence staining, periostin was able to double the proliferation rate as similar to that achieved by the positive control FGF-2 (Fig. 1) ; in terms of cell migration, periostin was able to accelerate wound closure even faster than the positive control FGF-2 (Fig. 2) . On the other hand, the effects of P. gingivalis LPS and TNF-a have been also studied. A summative effect between both factors has been extensively studied (29) (30) (31) (32) . LPS can directly induce cell death or apoptosis in many cell types, including macrophages, vascular endothelial cells, hepatocytes and myocytes. In contrast, LPS has an anti-apoptotic effect on neutrophils both in vivo and in vitro (31) . In a similar way, it is commonly accepted that members of the TNF superfamily mediate either proliferation, survival or apoptosis of cells (33) . Furthermore, during the inflammatory process, TNF-a, mediated or not by LPS, also stimulates the release of matrix metalloproteinases and other products that enhance tissue destruction (31) . Previous studies have also shown an indirect effect of bacterial LPS on apoptosis of PDL cells through the induction of TNF-a production (31) and TNFR1 (34) .
Within the context of the present study, we have observed a reduction in proliferation by the effects of P. gingivalis LPS and TNF-a combined, although the differences were not statistically significant. This apparent discrepancy might be due to specific characteristics of the experiments to detect Ki67 in terms of cell confluence and duration of the exposure to that challenge. Interestingly, and important within the context of periodontal regeneration, in a challenged situation, the addition of periostin promoted cell proliferation to a similar level as FGF-2 (Fig. 4) , but not as much as the effects achieved when P. gingivalis LPS and TNF-a were not present (Fig. 1) ; the effect seems to be reduced (possible competition with TNF-a/LPS), but not completely cancelled.
It is interesting that phosphorylation of AKT and protein S6 with the addition of periostin 100 ng/mL is actually decreased under non-challenged conditions. The reason for this is not clear at this moment but we can speculate that higher doses of periostin may actually exert a limiting or inhibitory effect, as seen with other molecules and growth factors such as platelet-derived growth factor (35, 36) . The fact that we observed other effects with that dose (Ki-67 and migration), rather than contradict this plausible explanation, suggests a possible supplementary mechanism different than that involving AKT and PS6.
However, to achieve true periodontal regeneration, not only proliferation is needed. Migration of the appropriate cells into the healing area is key during the initial phases. PDL cells are capable of differentiating into cementogenic or osteogenic lineage cells (37) (38) (39) . Therefore, PDL . Also, note the significantly faster area reduction compared to TNF-a+P. gingivalis LPS after treatment with periostin 100 ng/mL (dotted green line), periostin 50 ng/mL (dotted orange line) and FGF-2 (dotted purple line). Area reduction was initially faster for both periostin treatments, but after 12-18 h only FGF-2 and periostin 50 ng/mL accelerate hPDL migration at a higher rate comparable to non-challenged control. n = 216 (four conditions, two cell lines, three experiments, triplicates per condition, three images per replicate). FGF, fibroblast growth factor; hPDL, human periodontal ligament; LPS, lipopolysaccharide; TNF, tumor necrosis factor. cells are essential not only for the maintenance but also for regeneration of the periodontium (40) . hPDL cell migration in the present study was significantly increased by periostin at 50 ng/mL, even at very early time points (Fig. 2) . Furthermore, in a context of disease-simulated conditions, with the addition of TNF-a and P. gingivalis LPS, hPDL migration was significantly reduced (Fig. 5) . In this challenged scenario, periostin recovered the migration potential of hPDL cells to levels not significantly different as those achieved with the addition of the positive control FGF-2 or the non-challenged control group. These are key mechanisms, as occupying the space with this specific cell population with multipotent capacities (PDL cells) could lead to the regeneration of the area reducing the chances of formation of reparative tissues. FGF-2, used in this study as positive control, has been used, among other applications, in clinical studies for periodontal tissue regeneration (41, 42) due to the activation of a plethora of cellular events: proliferative responses of PDL cells through the extracellular signal-regulated kinase (ERK) 1/2 signaling molecule (43, 44) , cell migration via PI3K/AKT signaling (44, 45) , and regulatory effects of ECM production and PDL cell differentiation (46) . FGF-2 seems to act on immature PDL cells to stimulate proliferation while suppressing differentiation into hard tissueforming cells. During the subsequent healing processes, PDL cells begin to differentiate, inducing periodontal tissue regeneration (46) . In contrast, different studies have shown that FGF-stimulated effects are partially inhibited by TNF-a (47) .
The effects achieved in this study with the application of FGF-2 are comparable to those obtained with periostin. Therefore, periostin may become a promising agent in periodontal regeneration with some important advantages as it integrates a spectrum of key events in matrixcellular interactions: accelerates hPDL cell migration, favors hPDL cell proliferation, promotes angiogenesis and, finally and decisively, will promote a mechanically stable ECM suitable to support periodontal tissue stability with a higher specificity for the PDL. Migration and proliferation, although related, are different processes. Studying these processes in vitro is complicated. Therefore, further studies to confirm the optimum concentration for each process and the combination of both are needed as well as in vivo studies to confirm these observations.
Conclusion
Periostin, a key factor for periodontal integrity, is involved in important cellular events, such as cell proliferation, migration and activation of the survival signaling pathway PI3K/AKT/ mTOR. Such effects may support the use of periostin as a novel biological agent for periodontal regeneration purposes. Further studies of the specific mechanisms, protein concentrations, timely assessment and the regenerative value of periostin in animal studies are needed.
